EGFR and neoplasm: The authors also reported histology transformation in tumors with acquired resistance; five patients with lung adenocarcinoma before EGFR-TKI treatment were found to have small-cell lung cancer (SCLC) in drug-resistant tumor biopsies, while retaining the original EGFR mutation 53.